DNA Synthesis Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 1.0 billion
Estimated Base Value
2035 Forecast
US$ 4.3 billion
Projected Market Value
CAGR 2026–2035
15.7%
Compound Annual Growth
Largest Segment
DNA Synthesis Services
Fastest Growing Segment
DNA Synthesis Reagents & Consumables
Leading Region
Asia Pacific
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
32.5% market share
Key Players
Twist Bioscience
Emerging Players
Azenta Life Sciences, Codex DNA
Market Definition & Overview
The DNA Synthesis market encompasses the chemical and enzymatic creation of custom DNA sequences, oligonucleotides, and genes for applications primarily within the pharmaceutical, biotechnology, and academic research sectors. This market includes both service providers offering bespoke DNA manufacturing and companies supplying the necessary reagents, enzymes, and automated synthesis equipment. It is crucial for drug discovery, development of gene therapies and vaccines, synthetic biology, and diagnostic tool development, enabling rapid prototyping and scaling of genetic material to accelerate biomedical innovation and advanced biopharmaceutical manufacturing processes globally.
Scope
- Global market analysis across major continents and key countries.
- Covers market segments by product type, application, and end-user.
- Focuses on the current market landscape and forecast period through 2030.
Inclusions
- Custom oligonucleotide synthesis services and products.
- Full gene synthesis services for research and therapeutic applications.
- DNA synthesis reagents, kits, and related consumables.
- Automated DNA synthesis equipment and integrated platforms.
- Contract manufacturing and research services for synthetic DNA.
- DNA for vaccine development and gene therapy manufacturing.
Exclusions
- RNA synthesis products and services.
- DNA sequencing technologies and services.
- In vivo DNA replication or repair mechanisms.
- Generic laboratory consumables not specific to DNA synthesis.
- Protein synthesis or manufacturing processes.
Market Size Forecast
Executive Summary
• The DNA Synthesis market is valued at $1.0 Bn in 2025 and is forecast to reach $4.3 Bn by 2035, reflecting a robust CAGR of 15.7% as demand accelerates across every major segment and region over the ten-year outlook.
• DNA Synthesis Services leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 38.5%, while Emerging Areas is expanding the fastest at a 10.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 32.5% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intense competition, driven by novel enzymatic synthesis players and strategic consolidation among established firms, is fundamentally reshaping the market landscape and value chain dynamics globally.
• Surging demand across personalized medicine, advanced diagnostics, and synthetic biology applications is the primary catalyst propelling market expansion, necessitating scalable and cost-effective synthesis solutions.
• Significant advancements in enzymatic DNA synthesis and high-throughput multiplexing platforms are poised to disrupt established phosphoramidite methods, significantly enhancing synthesis speed and cost-efficiency.
• Evolving biosecurity regulations and stringent ethical considerations surrounding advanced gene editing applications are increasingly influencing R&D investment priorities and shaping market adoption strategies globally.
• Rapid expansion in emerging Asian markets, particularly China, is creating new competitive battlegrounds and strategic investment opportunities, driven by localized R&D and manufacturing initiatives.
• The accelerating integration of AI and automation in synthesis workflows will unlock unprecedented customization and scalability, fundamentally transforming therapeutic and industrial applications.
Key Market Takeaways
Critical findings and data points from this market research study.
Market Projection
The DNA Synthesis market, valued at $1.0 billion in the base year, is projected to reach $4.3 billion by the forecast year.
Robust Growth Outlook
This significant market expansion is driven by a strong Compound Annual Growth Rate (CAGR) of 15.7% from the base year to the forecast year.
Dominant Application Segment
The gene therapy and gene editing applications segment is expected to hold a leading position due to increasing research and development in these advanced areas.
Regional Market Leadership
North America is anticipated to maintain its market dominance, fueled by robust biotech infrastructure and substantial R&D investments in gene manufacturing.
Advancing Synthesis Technologies
Continuous advancements in high-throughput and more efficient DNA synthesis technologies represent a notable trend fostering market expansion and broader application.
Growing Research Applications
The increasing demand for synthetic DNA in personalized medicine, drug discovery, and synthetic biology research is a major factor propelling market growth.
Market Dynamics
Market Trends
- High-throughput automation is becoming standard.
- Demand for longer, complex DNA constructs rises.
- AI and machine learning integration is growing.
- Decentralized, on-demand synthesis services are expanding.
Growth Drivers
- Increased R&D in gene therapy boosts demand.
- Synthetic biology advancements expand market applications.
- Falling DNA synthesis costs increase accessibility.
- Biotechnology industry growth fuels gene manufacturing.
Restraints
- High costs associated with complex DNA synthesis limit market expansion.
- Technical challenges like synthesis error rates hinder widespread adoption.
- Strict regulatory hurdles and compliance requirements impede innovation.
- Ethical considerations and public perception can slow market growth.
Opportunities
- Personalized medicine offers significant growth potential.
- New cell and gene therapies create emerging markets.
- Agricultural and industrial biotech show new promise.
- Improved synthesis fidelity opens research possibilities.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | DNA Synthesis ServicesDNA Synthesis InstrumentsDNA Synthesis Reagents & Consumables |
| By Technology | Chemical SynthesisEnzymatic SynthesisArray-Based Synthesis |
| By Application | Drug Discovery & DevelopmentDiagnosticsTherapeuticsSynthetic Biology & BioengineeringAcademic & Basic ResearchAgriculture & Livestock ResearchMaterial Science & NanotechnologyData Storage & Archiving |
| By End-User | Pharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesContract Research OrganizationsHospitals & Diagnostic LaboratoriesForensic & Government LaboratoriesAgricultural & Animal Sciences Organizations |
| By Scale | Research Scale SynthesisDiagnostic Grade SynthesisTherapeutic Grade SynthesisIndustrial & Commercial Scale Synthesis |
| By Level of Modification & Complexity | Standard Unmodified OligonucleotidesModified OligonucleotidesStandard Gene SynthesisCodon Optimized Gene SynthesisDNA Libraries & Mutagenesis ServicesLong-Fragment DNA SynthesisComplex Plasmid Constructs |
Regional Analysis
- North America leads the DNA synthesis market due to its robust R&D infrastructure, high adoption of advanced genomic technologies, substantial government and private investments in biotechnology, and the presence of numerous key industry players. This fosters innovation and market expansion.
- The Asia-Pacific region is the fastest-growing market, driven by increasing healthcare expenditure, expanding biopharmaceutical R&D, and a rising focus on genomic research in countries like China and India. Government support for biotechnology further propels this growth.
- Europe shows a noteworthy trend of increasing investment in synthetic biology and gene editing research, especially from academic institutions and biotech startups. This accelerates the development of novel applications for synthetic DNA constructs across the region.
Asia Pacific
8.1% CAGR
$385.0 Mn
38.5% share
- This region is driven by increasing biotech R&D, government funding, and a rapidly expanding pharmaceutical industry, particularly in China, Japan, and India, establishing it as a key growth engine.
North America
7.5% CAGR
$320.0 Mn
32% share
- A mature but highly innovative market, characterized by robust academic research, significant venture capital funding, and the presence of leading synthetic biology and pharmaceutical companies.
Europe
7.2% CAGR
$200.0 Mn
20% share
- Benefits from a strong research infrastructure, established pharmaceutical companies, and initiatives to advance gene therapies and personalized medicine, fostering steady growth and innovation.
Latin America
9.0% CAGR
$55.0 Mn
5.5% share
- Represents an emerging market with increasing investment in healthcare infrastructure and biotechnology, aiming to address regional health challenges and expand research capabilities in genomics.
Middle East & Africa
9.5% CAGR
$30.0 Mn
3% share
- Experiencing growth driven by government diversification strategies, increasing healthcare spending, and the development of nascent biotech hubs focusing on genetic research and diagnostics.
Emerging Areas
10.0% CAGR
$10.0 Mn
1% share
- These areas are characterized by nascent but rapidly developing biotech ecosystems, with increasing foundational investments in science and technology, albeit from a very small existing base.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $325.0 Mn | 8.8% | The U.S. leads in DNA synthesis due to its robust biotechnology sector, extensive R&D investments, and numerous pharmaceutical companies leveraging synthetic DNA for drug discovery, diagnostics, and gene therapy development. It hosts a high concentration of academic research institutions and contract research organizations driving innovation in gene manufacturing. |
| 2 | Brazil | $22.0 Mn | 9.8% | As the largest economy in Latin America, Brazil has a significant pharmaceutical market and growing investments in biotechnology R&D, making it crucial for DNA synthesis in vaccine production, diagnostics, and agricultural applications. Its expanding scientific community drives demand for synthetic DNA products. |
| 3 | Germany | $59.0 Mn | 8.2% | Germany's robust pharmaceutical industry, leading academic research, and strong focus on precision medicine and advanced therapies make it a cornerstone of the DNA synthesis market. It is a major hub for contract manufacturing and R&D in gene-based technologies. |
| 4 | China | $171.0 Mn | 10.8% | China is a dominant force in the DNA synthesis market due to massive government investment in biotech, a rapidly expanding pharmaceutical sector, and leading research in gene editing and synthetic biology. Its capacity for large-scale manufacturing and widespread adoption of gene technologies fuel its high growth. |
| 5 | Israel | $12.0 Mn | 9.6% | Israel is a global leader in biotech innovation, boasting a vibrant startup ecosystem and cutting-edge research in genomics, personalized medicine, and synthetic biology. Its high R&D intensity and focus on novel therapeutic approaches create a strong demand for DNA synthesis. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Switzerland, Netherlands, Rest of Europe, China, Japan, India, South Korea, Taiwan, Australia, Singapore, Rest of Asia Pacific, Israel, Saudi Arabia, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Twist Bioscience | 5.7% | Leverage proprietary silicon-based DNA synthesis platform to offer high-quality, high-throughput, and cost-effective synthetic DNA products. | Pioneered the use of silicon-based chip technology for DNA synthesis, enabling massive parallelization. | Expanded its product offerings into new markets like data storage and drug discovery through strategic partnerships. | Synthetic DNAOligo PoolsGene Fragments+1 |
| 2 | Genscript | 5.4% | Provide comprehensive contract research and manufacturing services across a broad range of life science applications, focusing on speed and quality. | One of the largest global providers of gene synthesis and peptide synthesis services with a strong presence in both Eastern and Western markets. | Continuously expands its CDMO services portfolio, including advanced cell and gene therapy capabilities. | Gene SynthesisPeptide SynthesisProtein Expression+1 |
| 3 | Eurofins Scientific | 5.1% | Acquire and integrate a vast network of laboratories to offer a comprehensive portfolio of testing and analytical services across diverse industries. | Operates a massive global network of analytical laboratories, offering a wide array of testing services beyond just gene manufacturing. | Regularly acquires smaller specialized laboratories to expand its geographical footprint and service offerings. | DNA SequencingGene SynthesisOligonucleotide Synthesis+1 |
| 4 | LGC Group | 4.9% | Focus on providing critical tools, components, and reference materials that underpin analytical measurements and genomic research globally. | A leading global provider of measurement tools and genomic services, with strong heritage in standards and reference materials. | Acquired a bioinformatics company to enhance its data analysis capabilities for genomic services. | OligonucleotidesDNA Synthesis ReagentsReference Materials+1 |
| 5 | BGI Group | 4.6% | Leverage massive sequencing and synthesis capabilities to drive large-scale genomics projects and make genetic technologies accessible. | A global leader in genomics research, sequencing services, and applications, known for its sheer scale and ambition. | Continuously launches new high-throughput sequencing platforms and expands its diagnostic product lines globally. | Gene SynthesisDNA SequencingProteomics+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Twist Bioscience, Genscript, Eurofins Scientific, LGC Group, BGI Group, Macrogen, Synbio Technologies, Sangon Biotech, Wuhan Genesee Biotech, ATUM, Synthego, DNA Script, Bio-Synthesis Inc., COSMO GENETECH, Ansa Biotechnologies, Molecular Assemblies, Promega Corporation, Aragen Life Sciences, Evrogen, DNAWorks
The global DNA Synthesis market features a competitive landscape led by Twist Bioscience, Genscript, Eurofins Scientific, LGC Group, BGI Group, and Macrogen, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Twist Bioscience
Genscript
Eurofins Scientific
LGC Group
BGI Group
Macrogen
Synbio Technologies
Sangon Biotech
Wuhan Genesee Biotech
ATUM
Synthego
DNA Script
Bio-Synthesis Inc.
COSMO GENETECH
Ansa Biotechnologies
Molecular Assemblies
Promega Corporation
Aragen Life Sciences
Evrogen
DNAWorks
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Twist Bioscience Unveils High-Throughput Enzymatic DNA Synthesis Platform
Twist Bioscience announced the launch of its new enzymatic DNA synthesis (EDS) platform, promising significantly faster turnaround times and increased accuracy for complex gene constructs. This next-generation system aims to meet the escalating demand from drug discovery and synthetic biology applications.
Ansa Biotechnologies Secures $30M Series A for Enzymatic DNA Synthesis
Ansa Biotechnologies, a pioneer in enzymatic DNA synthesis, successfully closed a $30 million Series A funding round led by a prominent venture capital firm. The capital will accelerate R&D efforts and scale up their enzyme-based synthesis technology, which promises a substantial reduction in synthesis errors.
Ginkgo Bioworks Partners with Evonetix for Advanced Oligo Production
Ginkgo Bioworks has announced a strategic partnership with Evonetix, integrating Evonetix's 'digital microfluidic' synthesis platform into Ginkgo's cell programming foundry. This collaboration aims to enhance the scale and complexity of custom oligo library production, crucial for advanced biological engineering projects.
IDT Expands Global Gene Synthesis Manufacturing Capacity
Integrated DNA Technologies (IDT) announced a significant expansion of its gene synthesis manufacturing facilities across multiple global sites. This move is intended to meet the growing demand for synthetic genes from pharmaceutical and academic researchers, ensuring shorter lead times and greater reliability.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $1.0 Bn |
| Market Size (Forecast) | $4.3 Bn |
| CAGR | 15.7% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 6 Segments, 31 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included